{
    "nctId": "NCT01614002",
    "briefTitle": "A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer",
    "officialTitle": "Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region.",
    "overallStatus": "COMPLETED",
    "conditions": "Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 371,
    "primaryOutcomeMeasure": "the quantity of Doce onkovis needed pro treatment cycle",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Indication for Docetaxel according to the SmPC and treating physician\n\nExclusion Criteria:\n\n* according to the Docetaxel SmPC",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}